TY - JOUR
T1 - In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma
AU - Sanchez-Diaz, Patricia C.
AU - Hsiao, Tzu Hung
AU - Zou, Yi
AU - Sugalski, Aaron J.
AU - Heim-Hall, Josefine
AU - Chen, Yidong
AU - Langevin, Anne Marie
AU - Hung, Jaclyn Y.
N1 - Funding Information:
Funding for this work was provided in part by a National Institutes of Health NIH-NCATS UL1TR000149 CTSA grant through the Institute of Medicine and Science (IIMS) at the University of Texas Health Science Center at San Antonio, the NCI Cancer Center Support Grant 2 P30 CA054174-17 to Cancer Therapy and Research Center (CTRC), the Greehey Cancer Research Institute Permanent Health Fund Permanent Endowments-Higher Education (Children''s Cancer Research) at the University of Texas Health Science Center at San Antonio.
PY - 2014
Y1 - 2014
N2 - Purpose: Osteosarcoma is the most common bone tumor in children, adolescents, and young adults. In contrast to other childhood malignancies, no biomarkers have been consistently identified as predictors of outcome. This study was conducted to assess the microRNAs(miRs) expression signatures in pre-treatment osteosarcoma specimens and correlate with outcome to identify biomarkers for disease relapse. Results: A 42-miRs signature whose expression levels were associated with overall and relapse-free survival was identified. There were 8 common miRs between the two sets of survival-associated miRs. Bioinformatic analyses of these survivalassociated miRs suggested that they might regulate genes involved in ubiquitin proteasome system, TGFb, IGF, PTEN/AKT/mTOR, MAPK, PDGFR/RAF/MEK/ERK, and ErbB/HER pathways. Methods: The cohort consisted of 27 patients of 70% Mexican-American ethnicity. High-throughput RT-qPCR approach was used to generate quantitative expression of 754 miRs in the human genome. We examined tumor recurrence status, survival time and their association with miR expression levels by Cox proportional hazard regression analysis. TargetScan was used to predict miR/genes interactions, and functional analyses using KEGG, BioCarta, Gene Ontology were applied to these potential targets to predict deregulated pathways. Conclusions: Our findings suggested that these miRs might be potentially useful as prognostic biomarkers and therapeutic targets in pediatric osteosarcoma.
AB - Purpose: Osteosarcoma is the most common bone tumor in children, adolescents, and young adults. In contrast to other childhood malignancies, no biomarkers have been consistently identified as predictors of outcome. This study was conducted to assess the microRNAs(miRs) expression signatures in pre-treatment osteosarcoma specimens and correlate with outcome to identify biomarkers for disease relapse. Results: A 42-miRs signature whose expression levels were associated with overall and relapse-free survival was identified. There were 8 common miRs between the two sets of survival-associated miRs. Bioinformatic analyses of these survivalassociated miRs suggested that they might regulate genes involved in ubiquitin proteasome system, TGFb, IGF, PTEN/AKT/mTOR, MAPK, PDGFR/RAF/MEK/ERK, and ErbB/HER pathways. Methods: The cohort consisted of 27 patients of 70% Mexican-American ethnicity. High-throughput RT-qPCR approach was used to generate quantitative expression of 754 miRs in the human genome. We examined tumor recurrence status, survival time and their association with miR expression levels by Cox proportional hazard regression analysis. TargetScan was used to predict miR/genes interactions, and functional analyses using KEGG, BioCarta, Gene Ontology were applied to these potential targets to predict deregulated pathways. Conclusions: Our findings suggested that these miRs might be potentially useful as prognostic biomarkers and therapeutic targets in pediatric osteosarcoma.
KW - MicroRNA expression
KW - Osteosarcoma
KW - Pathways
KW - Pediatric cancers
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=84928749993&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928749993&partnerID=8YFLogxK
U2 - 10.18632/oncoscience.85
DO - 10.18632/oncoscience.85
M3 - Article
AN - SCOPUS:84928749993
SN - 2331-4737
VL - 1
SP - 599
EP - 608
JO - Oncoscience
JF - Oncoscience
IS - 9
ER -